MLYS Insider Trading

Insider Ownership Percentage: 33.24%
Insider Buying (Last 12 Months): $7,605,550.00
Insider Selling (Last 12 Months): $3,681,880.28

Mineralys Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Mineralys Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mineralys Therapeutics Share Price & Price History

Current Price: $12.58
Price Change: Price Decrease of -0.11 (-0.87%)
As of 06/14/2024 01:00 AM ET

This chart shows the closing price history over time for MLYS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Mineralys Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/14/2024Jon CongletonCEOSell16,229$12.52$203,187.08976,271View SEC Filing Icon  
6/12/2024Jon CongletonCEOSell16,607$12.77$212,071.391,032,461View SEC Filing Icon  
6/11/2024Adam Scott LevyCFOSell96,815$12.94$1,252,786.10255,462View SEC Filing Icon  
5/9/2024David Malcom RodmanInsiderSell100$15.00$1,500.0066,997View SEC Filing Icon  
2/12/2024Samsara Biocapital Gp, LlcMajor ShareholderBuy555,555$13.50$7,499,992.505,074,916View SEC Filing Icon  
11/22/2023Jon CongletonCEOBuy4,250$5.97$25,372.501,049,068View SEC Filing Icon  
9/6/2023Jon CongletonCEOBuy2,250$12.08$27,180.001,044,818View SEC Filing Icon  
8/17/2023Jon CongletonCEOBuy2,250$12.10$27,225.001,042,568View SEC Filing Icon  
8/11/2023David Malcom RodmaninsiderSell157,091$12.81$2,012,335.71View SEC Filing Icon  
8/11/2023Jon CongletonCEOBuy2,000$12.89$25,780.001,040,318View SEC Filing Icon  
2/14/2023Adam Scott LevyCFOBuy6,250$16.00$100,000.00350,811View SEC Filing Icon  
2/14/2023Hbm Healthcare Investments (CaMajor ShareholderBuy312,500$16.00$5,000,000.003,218,106View SEC Filing Icon  
2/14/2023Ra Capital Management, L.P.DirectorBuy1,250,000$16.00$20,000,000.001,867,229View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Mineralys Therapeutics (NASDAQ:MLYS)

84.46% of Mineralys Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MLYS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Mineralys Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024RA Capital Management L.P.4,850,984$62.63M0.8%+52.6%9.770%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System1,953$25K0.0%-38.9%0.004%Search for SEC Filing on Google Icon
5/15/2024Bellevue Group AG9,200$0.12M0.0%N/A0.019%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC327,959$4.23M0.5%N/A0.661%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC4,632$60K0.1%-30.4%0.009%Search for SEC Filing on Google Icon
5/14/2024SR One Capital Management LP2,016,822$26.04M7.2%+12.4%4.062%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.982,932$12.69M0.0%+0.5%1.980%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.7,931$0.10M0.0%+67.0%0.016%Search for SEC Filing on Google Icon
3/22/2024PNC Financial Services Group Inc.4,122$35K0.0%+17,821.7%0.010%Search for SEC Filing on Google Icon
2/14/2024Catalys Pacific LLC9,194,579$79.07M74.1%N/A22.371%Search for SEC Filing on Google Icon
2/14/2024Pale Fire Capital SE34,743$0.30M0.0%N/A0.085%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.605,606$5.21M2.2%-28.0%1.473%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 2,879$25K0.0%-71.4%0.007%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC23,973$0.21M0.0%N/A0.058%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.699,467$6.02M0.0%+55.4%1.702%Search for SEC Filing on Google Icon
2/9/2024CreativeOne Wealth LLC10,750$92K0.0%N/A0.026%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC20,500$0.18M0.0%-37.3%0.050%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.5,779$50K0.0%-43.2%0.014%Search for SEC Filing on Google Icon
2/1/2024CWM LLC5,891$51K0.0%+120.0%0.014%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.20,032$0.17M0.0%-10.1%0.049%Search for SEC Filing on Google Icon
1/30/2024Cornercap Investment Counsel Inc.22,209$0.19M0.0%N/A0.054%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.4,750$41K0.0%N/A0.012%Search for SEC Filing on Google Icon
1/16/2024Raymond James Financial Services Advisors Inc.14,611$0.13M0.0%-64.0%0.036%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC10,093$87K0.0%N/A0.025%Search for SEC Filing on Google Icon
11/15/2023Sectoral Asset Management Inc.840,759$8M1.6%+36.8%2.046%Search for SEC Filing on Google Icon
11/15/2023Laurion Capital Management LP969,978$9.22M0.1%+42.6%2.360%Search for SEC Filing on Google Icon
11/14/2023Braidwell LP2,023,900$19.25M0.6%+267.8%4.924%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC192,362$1.83M0.0%+64.3%0.468%Search for SEC Filing on Google Icon
11/13/2023CHI Advisors LLC568,379$5.41M1.6%N/A1.383%Search for SEC Filing on Google Icon
11/13/2023Federated Hermes Inc.22,293$0.21M0.0%+8.3%0.054%Search for SEC Filing on Google Icon
11/13/2023FMR LLC1,188,653$11.30M0.0%+62.6%2.892%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC32,700$0.31M0.0%N/A0.080%Search for SEC Filing on Google Icon
10/24/2023Raymond James Financial Services Advisors Inc.40,578$0.39M0.0%N/A0.099%Search for SEC Filing on Google Icon
10/11/2023CWM LLC2,678$25K0.0%N/A0.007%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC2,778$47K0.0%-77.8%0.007%Search for SEC Filing on Google Icon
8/15/2023Sphera Funds Management LTD.405,400$6.91M1.1%+19.6%0.992%Search for SEC Filing on Google Icon
8/14/2023Great Point Partners LLC546,059$9.31M1.8%-12.0%1.336%Search for SEC Filing on Google Icon
8/14/2023Driehaus Capital Management LLC499,983$8.53M0.1%+10.4%1.224%Search for SEC Filing on Google Icon
8/11/2023Panagora Asset Management Inc.23,016$0.39M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/11/2023Sectoral Asset Management Inc.614,713$10.48M1.7%+0.2%1.504%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP193,525$3.30M0.0%+6.7%0.474%Search for SEC Filing on Google Icon
8/10/2023Letko Brosseau & Associates Inc.11,400$0.19M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.6,717$0.12M0.0%+15.0%0.016%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can101,724$1.51M0.0%N/A0.249%Search for SEC Filing on Google Icon
5/19/2023SR One Capital Management LP1,794,600$28.10M9.5%N/A4.392%Search for SEC Filing on Google Icon
5/16/2023Great Point Partners LLC620,326$9.71M1.9%N/A1.518%Search for SEC Filing on Google Icon
5/16/2023Ghisallo Capital Management LLC10,000$0.16M0.0%N/A0.024%Search for SEC Filing on Google Icon
5/15/2023Affinity Asset Advisors LLC62,500$0.98M0.3%N/A0.153%Search for SEC Filing on Google Icon
5/15/2023Logos Global Management LP300,000$4.70M0.7%N/A0.734%Search for SEC Filing on Google Icon
5/15/2023RTW Investments LP922,100$14.44M0.3%N/A2.257%Search for SEC Filing on Google Icon
5/12/2023Sectoral Asset Management Inc.613,233$9.60M1.8%N/A1.501%Search for SEC Filing on Google Icon
5/11/2023ExodusPoint Capital Management LP181,312$2.84M0.0%N/A0.444%Search for SEC Filing on Google Icon
5/11/2023American Century Companies Inc.417,903$6.53M0.0%N/A1.023%Search for SEC Filing on Google Icon
5/5/2023Monashee Investment Management LLC110,000$1.72M0.5%N/A0.269%Search for SEC Filing on Google Icon
4/27/2023Strs Ohio2,500$39K0.0%N/A0.006%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Mineralys Therapeutics logo
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kidney diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Read More on Mineralys Therapeutics

Today's Range

Now: $12.58
Low: $12.37
High: $12.64

50 Day Range

MA: $12.69
Low: $10.75
High: $14.65

52 Week Range

Now: $12.58
Low: $5.85
High: $17.44

Volume

105,832 shs

Average Volume

119,985 shs

Market Capitalization

$624.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03

Who are the company insiders with the largest holdings of Mineralys Therapeutics?

Mineralys Therapeutics' top insider shareholders include:
  1. Samsara Biocapital Gp, Llc (Major Shareholder)
  2. Hbm Healthcare Investments (Ca (Major Shareholder)
  3. Ra Capital Management, LP (Director)
  4. Jon Congleton (CEO)
  5. Adam Scott Levy (CFO)
  6. David Malcom Rodman (Insider)
Learn More about top insider investors at Mineralys Therapeutics.

Who are the major institutional investors of Mineralys Therapeutics?

Mineralys Therapeutics' top institutional investors include:
  1. RA Capital Management L.P. — 9.77%
  2. SR One Capital Management LP — 4.06%
  3. Vanguard Group Inc. — 1.98%
  4. Affinity Asset Advisors LLC — 0.66%
  5. Bellevue Group AG — 0.02%
  6. China Universal Asset Management Co. Ltd. — 0.02%
Learn More about top institutional investors of Mineralys Therapeutics stock.

Which major investors are selling Mineralys Therapeutics stock?

In the previous quarter, MLYS stock was sold by these institutional investors:
  1. EntryPoint Capital LLC
  2. California State Teachers Retirement System
In the last year, company insiders that have sold Mineralys Therapeutics company stock include:
  1. Samsara Biocapital Gp, Llc (Major Shareholder)
  2. Hbm Healthcare Investments (Ca (Major Shareholder)
  3. Ra Capital Management, LP (Director)
Learn More investors selling Mineralys Therapeutics stock.

Which major investors are buying Mineralys Therapeutics stock?

During the last quarter, MLYS stock was purchased by institutional investors including:
  1. RA Capital Management L.P.
  2. Affinity Asset Advisors LLC
  3. SR One Capital Management LP
  4. Bellevue Group AG
  5. Vanguard Group Inc.
  6. China Universal Asset Management Co. Ltd.
In the previous year, these company insiders have bought Mineralys Therapeutics stock:
  1. Samsara Biocapital Gp, Llc (Major Shareholder)
  2. Hbm Healthcare Investments (Ca (Major Shareholder)
  3. Ra Capital Management, LP (Director)
  4. Jon Congleton (CEO)
  5. Adam Scott Levy (CFO)
Learn More investors buying Mineralys Therapeutics stock.